ENVOTON

ENVOTON (Dydrogesterone) 20 Tablets of 10mg. It is commonly used in women for menstrual and pregnancy-related conditions, such as infertility due to low progesterone levels, threatened miscarriage, and irregular menstrual periods.

Package Contains: Each ENVOTON package contains 20 tablets of 10mg & a leaflet.

Composition: Each film-coated tablet contains:

Dydrogesterone 10mg

(USP Specifications)

Dosage & Administration: As directed by the physician.

Uses: It is commonly used to treat:

Irregular menstrual periods.
Painful menstruation.
Premenstrual syndrome (PMS).
Endometriosis.
Infertility due to low progesterone levels.
Support during early pregnancy.
Threatened or recurrent miscarriage.
Abnormal uterine bleeding.
Hormone replacement therapy (HRT) with estrogen.
Secondary amenorrhea (absence of periods).

Side Effects: The adverse effects of this product were most commonly reported in patients who were treated with dydrogesterone during clinical trials into indications without the use of oestrogen, such as metrorrhagia, painful, sensitive breasts, and migraine/headache. The following adverse effects, with the frequencies indicated, were observed during clinical trials with dydrogesterone (n=3,483) for indications without the use of oestrogen therapy.

Contraindications:

Vaginal bleeding, where the cause has not been established.
Presence of serious liver disorders, or serious liver disorders in the medical history, until the liver function values have returned to normal.
Contraindications for use of oestrogens in combination with progestogens such as dydrogesterone in combined therapy. Known hypersensitivity to dydrogesterone or any of the excipients.
Known or suspected sex hormone-dependent malignancies.

Special warnings and precautions for use: Before starting treatment with dydrogesterone because of dysfunctional uterine bleeding an organic cause should be excluded. Breakthrough bleeding and spotting may occur during the first months of treatment. If breakthrough bleeding and spotting continue to occur when treatment has already been underway for some time, or continue when treatment is discontinued, the cause of this should be ascertained, if necessary by taking an endometrial biopsy to exclude malignancy of the endometrium. If one of the following disorders occurs during use for the first time or gets worse, stopping the treatment should be considered:

exceptionally severe headache, migraine or symptoms that may indicate cerebral ischemia.
marked increase in blood pressure.
occurrence of venous thromboembolism.

Fertility, pregnancy and lactation:

Pregnancy: It is estimated that over 9 million women have already been exposed to dydrogesterone during pregnancy. To date there were no indications that the use of dydrogesterone during pregnancy has a harmful effect. Clinical trials in which a limited number of women were treated with dydrogesterone in the first stage of pregnancy did not show that the risk is increased. Dydrogesterone may be administered during pregnancy if there is a clear indication for this.

Lactation: It is not known whether dydrogesterone is excreted in breast milk. No research has been done into the excretion of dydrogesterone in breast milk. Experiences with other progestogens indicate that progestogens and their metabolites are found in small quantities in breast milk. It is not known whether there is a risk for the child. Dydrogesterone should therefore not be used while breastfeeding.

Fertility: There are no data on the effect of dydrogesterone on fertility.

Instruction: Store below 30°C. Protect from heat, sunlight & moisture. Keep all medicine out of the reach of children. To be sold on prescription of Registered Medical Practitioner only.

Manufacturer & Buy Online:

ENVOTON tablets are manufactured by: WnsFeild Pharmaceuticals.

This is the link to the manufacturer: https://www.wnsfeild

It is not available online, but you can buy it from any nearby pharmacy. It is currently (2026) available at the retail price of around 1590 rupees.

By: Urooj